Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Bridel, Claire, van Wieringen, Wessel N., Zetterberg, Henrik, Tijms, Betty M., Teunissen, Charlotte E., and the NFL Group, Alvarez-Cermeño, José C., Andreasson, Ulf +70 more·2019·JAMA Neurology

DOI 10.1001/jamaneurol.2019.1534

Cited by (771)

Items 301–400 of 771

Neurofilament Light (NF-L) Chain Protein from a Highly Polymerized Structural Component of the Neuronal Cytoskeleton to a Neurodegenerative Disease Biomarker in the Periphery
Walter J Lukiw · 2021 · Alzheimer’s & Neurodegenerative Diseases
Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis
Wenyi Kou, Siming Li, Rui Yan, Junjiao Zhang, Zhirong Wan, Tao Feng · 2025 · Journal of Neurology
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview
Constance Delaby, Aurélie Ladang, Jose Martinez‐Yriarte, Chiara Zecca, Giancarlo Logroscino, Péter Körtvelyessy, Hayrettin Tumani, Piero Parchi, Isabelle Quadrio, Melanie Hart et al. · 2025 · Alzheimer s & Dementia
Fluid biomarkers for neurodegenerative diseases: a comprehensive update
Martina Valletta, Nils Briel, Idil Yuksekel, Michelle C. Barboure, A. R. Coward, Julie F. H. De Houwer, Ayesha Fawad, Alberto González-Mayoral, Gianmarco Iaccarino, Francisco Martínez‐Dubarbie et al. · 2025 · Alzheimer s Research & Therapy
Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer
Amélie Darlix, Christophe Hirtz, Caroline Mollévi, Nelly Ginestet, Laurent Tiers, William Jacot, Sylvain Lehmann · 2021 · International Journal of Cancer
Blood Neurofilament Light Chain in Genetic Ataxia: A Meta‐Analysis
Linliu Peng, Shang Wang, Zhao Chen, Yun Peng, Chunrong Wang, Zhe Long, Huirong Peng, Yuting Shi, Xuan Hou, Lijing Lei et al. · 2021 · Movement Disorders
The role of neurofilament light in genetic frontotemporal lobar degeneration
Zetterberg, Henrik, Teunissen, Charlotte, van Swieten, John, Kuhle, Jens, Boxer, Adam, Rohrer, Jonathan D, Mitic, Laura, Nicholson, Alexandra M, Pearlman, Rodney, McCaughey, Stella Mayo et al. · 2022 · Brain Communications
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders
Matthew JY Kang, Dhamidhu Eratne, Hannah Dobson, Charles Benjamin Malpas, Michael H Keem, Courtney Lewis, Jasleen Kaur Grewal, Vivian Tsoukra, Christa Dang, Ramon Mocellin et al. · 2023 · Acta Neuropsychiatrica
Multiple Sclerosis: From the Application of Oligoclonal Bands to Novel Potential Biomarkers
Grazia Maglio, Marina D’Agostino, Francesco Pio Caronte, Luciano Pezone, Amelia Casamassimi, Monica Rienzo, Erika Di Zazzo, Carmela Nappo, Nicola Medici, Anna Maria Molinari et al. · 2024 · International Journal of Molecular Sciences
Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer’s disease
Lewis K. Penny, Richard A. Lofthouse, Mohammad Arastoo, Andy Porter, Soumya Palliyil, Charles R. Harrington, Claude M. Wischik · 2024 · Translational Neurodegeneration
Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament light
Georgia M. Parkin, Elizabeth A. Thomas, Jody Corey‐Bloom · 2024 · EBioMedicine
Cerebrospinal Fluid Levels of Prodynorphin‐Derived Peptides are Decreased in Huntington's Disease
MHD Rami Al Shweiki, Patrick Oeckl, Adrian Pachollek, Petra Steinacker, Peggy Barschke, Steffen Halbgebauer, Sarah Anderl‐Straub, Jan Lewerenz, Albert Christian Ludolph, G. Bernhard Landwehrmeyer et al. · 2020 · Movement Disorders
Key biomarkers in Alzheimer’s disease: Insights for diagnosis and treatment strategies
Ruqaiya Jamal, Mohammad Abuzar Shaikh, Mohamad Taleuzzaman, Ziyaul Haque, Mohammed Albratty, Md Shamsher Alam, Hafiz Antar Makeen, Khalid A. Zoghebi, Safaa Fathy Saleh · 2025 · Journal of Alzheimer s Disease
CSF and Circulating NfL as Biomarkers for the Discrimination of Parkinson Disease From Atypical Parkinsonian Syndromes
Efthalia Angelopoulou, Anastasia M. Bougea, Ανδρέας Παπαδόπουλος, Nikolaos Papagiannakis, Athina‐Maria Simitsi, Christos Koros, Marios K. Georgakis, Leonidas Stefanis · 2021 · Neurology Clinical Practice
CSF biomarkers for dementia
Ashvini Keshavan, Frankie O’Shea, Miles D. Chapman, Melanie Hart, Michael Peter Lunn, Ross W. Paterson, Jonathan Daniel Rohrer, Catherine Jane Mummery, Nick C. Fox, Henrik Zetterberg et al. · 2022 · Practical Neurology
Multi-Omics Interdisciplinary Research Integration to Accelerate Dementia Biomarker Development (MIRIADE)
Ekaterina Mavrina, Leighann Eileithyia Kimble, Katharina Waury, Dea Gogishvili, Nerea Gómez de San José, Shreyasee Das, Salomé Coppens, Bárbara Fernandes Gomes, Sára Mravinacová, Anna Lidia Wojdała et al. · 2022 · Frontiers in Neurology
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
Kirsten E. J. Wesenhagen, Betty Marije Tijms, Lynn Boonkamp, Patty L. Hoede, Julie Goossens, Nele Dewit, Philip Scheltens, Eugeen Vanmechelen, Pieter Jelle Visser, Charlotte Elisabeth Teunissen · 2022 · Alzheimer s Research & Therapy
Sex differences in early‐onset Alzheimer's disease
José Contador, Agnès Pérez‐Millan, Núria Guillén, Jordi Sarto, Adrià Tort‐Merino, Mircea Balasa, Neus Falgàs, Magdalena Castellví, Sergi Borrego‐Écija, Jordi Juncà‐Parella et al. · 2022 · European Journal of Neurology
Brain-derived neurotrophic factor, neurofilament light and glial fibrillary acidic protein do not change in response to aerobic training in people with MS-related fatigue – a secondary analysis of a randomized controlled trial
Arianne Sophia Gravesteijn, Heleen Beckerman, Eline A.J. Willemse, Hanneke E. Hulst, Brigit A. de Jong, Charlotte Elisabeth Teunissen, Vincent de Groot · 2022 · Multiple Sclerosis and Related Disorders
Serum neurofilament light chain and cognition decline in US elderly: A cross‐sectional study
Xiangqiang Liu, Jun Chen, Chen Meng, Lan Zhou, Yong Liu · 2023 · Annals of Clinical and Translational Neurology
Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness
Anja Hviid Simonsen, Helena Sophia Gleerup, Christian Sandøe Musaeus, Finn Thorup Sellebjerg, Malene Bredahl Hansen, Helle Bach Søndergaard, Gunhild Waldemar, Steen Gregers Hasselbalch · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly
Mikko Koivumäki, Laura L. Ekblad, Juan Lantero‐Rodriguez, Nicholas James Ashton, Thomas K. Karikari, Semi Helin, Riitta K Parkkola, Jyrki M. P. Lötjönen, Henrik Zetterberg, Kaj Blennow et al. · 2024 · Alzheimer s Research & Therapy
High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS
Christoffer Rosén, Bernardo Mitre, Bengt Nellgård, Markus Axelsson, Radu Constantinescu, Peter Munch Andersen, Keti Dalla, Kaj Blennow, Gustav Nilsson, Henrik Zetterberg et al. · 2024 · Journal of the Neurological Sciences
PP2A subunit PPP2R2C is downregulated in the brains of Alzheimer’s transgenic mice
Waiian Leong, Wei Lin Xu, Bo Wang, Shuaiyun Gao, Xiuyun Zhai, Cuicui Wang, Éric Gilson, Jing Ye, Yiming Lu · 2020 · Aging
Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS
Joakim Bergman, Anders Svenningsson, Per Liv, Tommy A. Bergenheim, Joachim Burman · 2020 · Fluids and Barriers of the CNS
Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
Julia Remnestål, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, Anna Zettergren, Silke Kern, Ingmar Gr. Skoog et al. · 2021 · Alzheimer s Research & Therapy
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus
Heikki Lukkarinen, Ina C. Tesseur, Darrel J. Pemberton, Peter D van der Ark, Maarten Timmers, Randy Slemmon, Luc Janssens, Johannes Rolf Streffer, Luc Van Nueten, Astrid Bottelbergs et al. · 2021 · Journal of Alzheimer s Disease
Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis
Stephanie N. Blandford, Dylan A. Galloway, John Bradley Williams, Shane Thomas Arsenault, Janet Elizabeth Brown, Gregg MacLean, G. R. Wayne Moore, Jane Barron, Michelle Ploughman, Fraser Clift et al. · 2021 · Multiple Sclerosis and Related Disorders
NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline
Constance Delaby, Ana Guinovart Julian, Guylène Page, Stéphanie Ragot, Sylvain Lehmann, Marc Paccalin · 2021 · Scientific Reports
Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
Roberta Zanardini, Claudia Saraceno, Luisa Benussi, Rosanna Squitti, Roberta Ghidoni · 2022 · Frontiers in Neuroscience
Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma
Nora Woltsche, Katharina Valentin, Lukas Hoeflechner, Andreas Guttmann, Jutta Horwath‐Winter, Mona Regina Schneider, Domagoj Ivastinović, Marlene Lindner, Leopold F. Schmetterer, Neena Singh et al. · 2022 · British Journal of Ophthalmology
Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis
Rodolfo A. Kölliker Frers, Matilde E. Otero Losada, Tamara Kobiec, Lucas Udovin, María Laura Aón Bertolino, María Inés Herrera, Francisco Capani · 2022 · Frontiers in Immunology
Neurofilaments in neurologic disorders and beyond
Gloria K. Mak, Suresh Menon, Jian‐Qiang Lu · 2022 · Journal of the Neurological Sciences
Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women
X. Capó, A. M. Galmés-Panadés, C. Navas-Enamorado, A. Ortega-Moral, Silvia Marín, M. Cascante, A. Sánchez-Polo, Lluís Masmiquel, Margalida Torrens-Mas, M. Gonzalez-Freire · 2023 · International Journal of Molecular Sciences
Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis
Ulf Kläppe, Stefan Sennfält, Anikó Lovik, Anja Finn, Ulrika Bofaisal, Henrik Zetterberg, Kaj Blennow, Fredrik Piehl, Ivan Kmezic, Rayomand Press et al. · 2023 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA
Sanskriti Rai, Prahalad Singh Bharti, Rishabh Singh, Simran Rastogi, Komal Rani, Vaibhav Sharma, Priya Kumari Gorai, Neerja Rani, Bhupendra Verma, Thota Jagadeshwar Reddy et al. · 2023 · Frontiers in Neuroscience
Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis
Maximilian Vidovic, Hanna Sophie Lapp, Constanze Weber, Lydia Plitzko, Michael Seifert, Petra Steinacker, Markus Otto, Andreas Hermann, René Günther · 2024 · Brain Communications
Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research
Karen Nuytemans, Sanne Franzen, Iris Broce, Paulo Caramelli, Ratnavalli Ellajosyula, Elizabeth C. Finger, Veer Bala Gupta, Vivek Gupta, Ignacio Illán‐Gala, Samantha M. Loi et al. · 2024 · Alzheimer s & Dementia
Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke
Peng Wang, Jia Fan, Ling Yuan, Yi Nan, Shanji Nan · 2020 · Neurotoxicity Research
Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease
Franc Llorens, Anna Villar‐Piqué, Péter Hermann, Matthias Schmitz, Olga Calero, Christiane Stehmann, Shannon Sarros, Fabio Moda, Isidró Ferrer, Anna Poleggi et al. · 2020 · Biomolecules
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
Christoph Kessler, Lina María Serna-Higuita, Tim W. Rattay, Walter Maetzler, Isabel Wurster, Stefanie N. Hayer, Carlo Wilke, Holger Hengel, Jennifer Reichbauer, Marcel Armbruster et al. · 2021 · Annals of Clinical and Translational Neurology
Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia
Ignacio Álvarez, Mónica Díez-Fairén, Miquel Aguilar, Jose Manuel González, Montse Ysamat, Juan Pablo Tartari, María Cárcel, Álvaro Alonso, Britta Brix, Philipp Arendt et al. · 2020 · European Journal of Neurology
Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
Frauke Stascheit, Benjamin A. Hotter, Sarah Klose, Christian Meisel, Andreas Meisel, Juliane Klehmet · 2021 · Frontiers in Neurology
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
David Reyes‐Leiva, Oriol Dols‐Icardo, Sònia Sirisi, Elena Cortés‐Vicente, Janina Turón‐Sans, Noemí de Luna, Rafael Blesa, Olivia Belbin, Víctor Montal, Daniel Andres Alcolea et al. · 2022 · Frontiers in Neurology
An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis
Marwa Kaisey, Ghazal Lashgari, Justyna Fert‐Bober, Daniel Ontaneda, Andrew J Solomon, Nancy L. Sicotte · 2022 · Current Neurology and Neuroscience Reports
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting
Michael Seiberl, Julia Feige, Patrick Hilpold, Wolfgang Hitzl, Lukas Machegger, Arabella Buchmann, Michael Khalil, Eugen Trinka, Andrea Harrer, Peter Wipfler et al. · 2023 · International Journal of Molecular Sciences
Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick‐borne encephalitis disease severity—a multicentre study on Lithuanian and Swedish patients
Malin Veje, Vytautas Griška, Jolita Pakalnienė, Auksė Mickienė, Daniel Bremell, Henrik Zetterberg, Kaj Blennow, Lars Lindquist, Marie Studahl · 2023 · European Journal of Neurology
Neurofilament light chain as a promising biomarker for depression diagnosis: a systematic review and meta-analysis
Adrina Habibzadeh, Vahid Reza Ostovan, Mohammad Amin Ghezel, Kiarash Kavari, Sina Kardeh, Reza Tabrizi · 2024 · BMC Psychiatry
Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting
Rebecca Z. Rousset, Thomas Claessen, Argonde C. van Harten, Afina Willemina Lemstra, Yolande A.L. Pijnenburg, Wiesje M. van der Flier, Anouk den Braber, Andreas Jeromin, Inge M.W. Verberk, Charlotte Elisabeth Teunissen · 2024 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
Sarah Aqel, Jamil Ahmad, Iman Saleh, Aseela Fathima, Asmaa A. Al Thani, Wael M.Y. Mohamed, Abdullah A. Shaito · 2025 · Biology
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
Kirsten E. J. Wesenhagen, Johan Gobom, Isabelle Bos, Stephanie J. B. Vos, Pablo Martínez‐Lage, Julius Popp, Magda Tsolaki, Rik R. Vandenberghe, Yvonne Freund‐Levi, Frans R.J. Verhey et al. · 2022 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Deciphering the factors that influence participation in studies requiring serial lumbar punctures
Gregory Scott Day, Tracy Rappai, Sushila Sathyan, John C. Morris · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review
Annemarie Thaele, Lorenzo Barba, Samir Abu‐Rumeileh, Matteo Foschi, Markus Otto · 2025 · Epilepsy & Behavior
Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications
Farah Anjum, Maha Mahfouz Bakhuraysah, Abdulaziz Alsharif, Taj Mohammad, Anas Shamsi, Md. Imtaiyaz Hassan · 2025 · Frontiers in Molecular Biosciences
Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria
Daniela Kern, Michael Khalil, Lukas Pirpamer, Arabella Buchmann, Edith Hofer, Peter Dal‐Bianco, Elisabeth Stögmann, Christoph Scherfler, Thomas Benke, Gerhard N. Ransmayr et al. · 2022 · Medicina
Neurofilament light chain in central nervous system infections: a prospective study of diagnostic accuracy
Ingeborg E. van Zeggeren, Liora ter Horst, Hans Heijst, Charlotte Elisabeth Teunissen, Diederik van de Beek, Matthijs C. Brouwer · 2022 · Scientific Reports
Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case–Control study
Frauke Stascheit, Annette Aigner, Philipp Mergenthaler, Benjamin A. Hotter, Sarah Hoffmann, Sophie Lehnerer, Christian Meisel, Andreas Meisel · 2023 · Frontiers in Neurology
Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid
Francisco J. Meda, Kathryn Knowles, Imogen J. Swift, Aitana Sogorb‐Esteve, Jonathan Daniel Rohrer, Anna Dittrich, Ingmar Gr. Skoog, Silke Kern, Bruno Becker, Kaj Blennow et al. · 2023 · BMJ Neurology Open
Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
Jia‐Hung Chen, Lung Chan, Chen‐Chih Chung, Oluwaseun Adebayo Bamodu, Chien‐Tai Hong · 2021 · Journal of Clinical Medicine
Preoperative Neurofilament Light Associated With Postoperative Delirium in Hip Fracture Repair Patients Without Dementia
Mfon E. Umoh, Haijuan Yan, Jeannie‐Marie Leoutsakos, Alexandria Lewis, Edward R. Marcantonio, Constantine George Lyketsos, Sharon K. Inouye, Abhay Moghekar, Karin J. Neufeld, Paul B. Rosenberg et al. · 2024 · Journal of the Academy of Consultation-Liaison Psychiatry
Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
Heekyoung Kang, Heejin Yoo, Jung‐Ah Lee, Soyeon Yoon, Henrik Zetterberg, Kaj Blennow, Fernando González‐Ortiz, Nicholas James Ashton, Theresa A. Day, Sung Hoon Kang et al. · 2025 · Alzheimer s Research & Therapy
Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy
Tojo Nakayama, Christelle Moufawad El Achkar, Lisseth Estefania Burbano, Imran H. Quraishi, J S Wu, M J Li, Yutaro Asami, Sean R Golinski, Emma Sherrill, Benjamin D. Goodlett et al. · 2026 · Nature Medicine
Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
Stefka Germanova Taneva, Svetla J. Todinova, Tonya D. Andreeva · 2023 · International Journal of Molecular Sciences
Comparison of Serum and Cerebrospinal Fluid Neurofilament Light Chain Concentrations Measured by Ella™ and Lumipulse™ in Patients with Cognitive Impairment
Teresa Urbano, Riccardo Maramotti, Manuela Tondelli, Chiara Gallingani, Chiara Carbone, Najara Iacovino, Giulia Vinceti, Giovanna Zamboni, Annalisa Chiari, Roberta Bedin · 2024 · Diagnostics
Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis
Helle Bach Søndergaard, Anna Olsson, Stefan Gustavsen, Cecilie Ammitzbøll, Lise Wegner Thørner, Erik Sørensen, Marie Krogh Nielsen, Josefine Britze, Signe Modvig, Poul Erik Jensen et al. · 2024 · Multiple Sclerosis and Related Disorders
Elevated serum neurofilament light chain in children autism spectrum disorder: A case control study
Weichao He, Xu-jie Zhang, You-qi Zhang, Weijie Zhang · 2020 · NeuroToxicology
Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis
Inge M.W. Verberk, Marleen J. A. Simmelink, Harry A. M. Twaalfhoven, Hugo Vrenken, Carsten Korth, Joep Killestein, Charlotte Elisabeth Teunissen, Claire Bridel · 2021 · Multiple Sclerosis and Related Disorders
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Anna L. Svenningsson, Erik Stomrud, Sebastian Palmqvist, Oskar Hansson, Rik Ossenkoppele · 2022 · Alzheimer s Research & Therapy
Plasma neurofilament light chain level is not a biomarker of Charcot–Marie–Tooth disease progression: Results of 3‐year follow‐up study
Signe Setlere, Arta Grosmane, Nataļja Kurjāne, Linda Gailīte, Dmitrijs Rots, Kaj Blennow, Henrik Zetterberg, Viktorija Ķēniņa · 2023 · European Journal of Neurology
Fluid biomarkers of vascular cognitive Impairment: From vascular pathophysiology to potential clinical applications
Xi Tao, Juan He, Yi Zhang, Yuqi Yin, Chen Guang Yang, Yunfeng Shang, Siyuan Wu · 2025 · Neuroscience
Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy
Takayoshi Tokutake, Kensaku Kasuga, Tamao Tsukie, Takanobu Ishiguro, Takayoshi Shimohata, Osamu Onodera, Takeshi Ikeuchi · 2022 · Parkinsonism & Related Disorders
Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
Christina Zjukovskaja, Anders O. Larsson, Honar Cherif, Kim Kultima, Joachim Burman · 2022 · Multiple Sclerosis and Related Disorders
Detection Analysis of Perioperative Plasma and CSF Reveals Risk Biomarkers of Postoperative Delirium of Parkinson’s Disease Patients Undergoing Deep Brain Stimulation of the Subthalamic Nuclei
Yongde Zhou, Yu Ma, Cuiping Yu, Yao Chen, Jian Hua Ding, Jianfeng Yu, Rongsong Zhou, Xiaoxiao Wang, Ting Fan, Chengmei Shi · 2022 · Clinical Interventions in Aging
Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span
Julia Elmers, Lorenza S. Colzato, Katja Akgün, Tjalf Ziemssen, Christian Beste · 2023 · Ageing Research Reviews
CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder
Amaia Muñoz Lopetegi, Simone Baiardi, Mircea Balasa, Angela Mammana, Gerard Mayà, Marcello Rossi, Mónica Serradell, Corrado Zenesini, Alice Ticca, Joan Santamaría et al. · 2024 · npj Parkinson s Disease
Drug repurposing in amyotrophic lateral sclerosis (ALS)
Emily Carroll, Jakub Scaber, K. Huber, Paul E. Brennan, Alexander G. Thompson, Martin R. Turner, Kevin Talbot · 2025 · Expert Opinion on Drug Discovery
Sex-related differences in genetically determined Alzheimer’s disease
Laura del Hoyo Soriano, Olivia Wagemann, Alexandre Bejanin, Johannes Levin, Juan Fortea · 2025 · Frontiers in Aging Neuroscience
Tracking the potential involvement of metabolic disease in Alzheimer's disease—Biomarkers and beyond
Jose Alejandro Luchsinger, Henrik Zetterberg · 2020 · International review of neurobiology
Night Watch on the Titanic: Detecting Early Signs of Epileptogenesis in Alzheimer Disease
Alice D. Lam, Jeffrey L. Noebels · 2020 · Epiliepsy currents/Epilepsy currents
Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases
Tobias Geis, Svena Gutzeit, Sotirios Fouzas, Andreas Ambrosch, Pascal Benkert, Jens Kühle, Sven Matthias Wellmann · 2023 · European Journal of Paediatric Neurology
Characterization of cerebrospinal fluid biomarkers associated with neurodegenerative diseases in healthy cynomolgus and rhesus macaque monkeys
Emma L. Robertson, Susan E. Boehnke, Natalia M. Lyra e Silva, Brittney Armitage‐Brown, Andrew Winterborn, Douglas J. Cook, Fernanda G. De Felice, Douglas P. Munoz · 2022 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer’s Disease
Wei-Na Yao, Xiao Zhang, Hui Zhao, Yun Xu, F. Bai · 2022 · Journal of Alzheimer's Disease
Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease
Yanan Xu, Hailun Jiang, Bin Zhu, Mingnan Cao, Tao Feng, Zhongshi Sun, Guanhua Du, Zhigang Zhao · 2023 · CNS Neuroscience & Therapeutics
Blood Biomarkers Discriminate Cerebral Amyloid Status and Cognitive Diagnosis when Collected with ACD-A Anticoagulant
Zachary D. Green, Paul J. Kueck, Casey S. John, Jeffrey Murray Burns, Jill K. Morris · 2023 · Current Alzheimer Research
Relationship between serum neurofilament light chain protein and depression: A nationwide survey and Mendelian randomization study
Xiangqiang Liu, Xiong Chen, Jun Chen · 2024 · Journal of Affective Disorders
The Impact of HIV on Early Brain Aging—A Pathophysiological (Re)View
Mihai Lazăr, Ruxandra Moroti, Ecaterina Constanța Barbu, Cristina Emilia Chițu, Cătălin Tilişcan, Teodora Maria Erculescu, Ruxandra Raluca Rosca, Stefan Frasila, Emma Teodora Schmilevschi, Vladimir Simion et al. · 2024 · Journal of Clinical Medicine
Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases
Sára Mravinacová, Sofia Bergström, Jennie Olofsson, Nerea Gómez de San José, Sarah Anderl‐Straub, Janine Diehl‐Schmid, Klaus C Fassbender, Klaus Fließbach, Holger Jahn, Johannes Kornhuber et al. · 2025 · Scientific Reports
Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
Ze-Hu Sheng, Lingzhi Ma, Jia-Yao Liu, Ya‐Nan Ou, Bing Tian Zhao, Ya‐Hui Ma, Lan Tan · 2022 · Frontiers in Aging Neuroscience
Association of plasma biomarkers with cognitive function in persons with dementia and cognitively healthy in the Democratic Republic of Congo
Jean N. Ikanga, Saranya Sundaram Patel, Blaine Russell Roberts, Megan Schwinne, Sabrina D. Hickle, Inge M.W. Verberk, Emmanuel Epenge, Guy Gikelekele, Nathan Tshengele, Immaculée Kavugho et al. · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study
Kunal Dhiman, Victor L. Villemagne, Christopher James Fowler, Pierrick Bourgeat, Qiao‐Xin Li, Steven John Collins, Ashley Ian Bush, Christopher Cleon Rowe, Colin Louis Masters, David J. Ames et al. · 2022 · Biomedicines
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Aníbal Sebastián Chertcoff, Raphaël Schneider, Christina J. Azevedo, Nancy L. Sicotte, Jiwon Oh · 2023 · Neurologic Clinics
Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
Julie J. McInvale, Peter Canoll, Gunnar Hargus · 2024 · Brain Pathology
Neurofilament Light Chain as a Biomarker of Global Cognition in Individuals With Possible Vascular Mild Cognitive Impairment
Amish Gaur, Damien Gallagher, Nathan Herrmann, Jinghan Jenny Chen, Susan Marzolini, PAUL I. OH, Yutaka Amemiya, Arun K. Seth, Alex Kiss, Krista L. Lanctôt · 2024 · Journal of Geriatric Psychiatry and Neurology
Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design
Rebecca Z. Rousset, Anouk den Braber, Inge M.W. Verberk, Lynn Boonkamp, David H. Wilson, Lannie Ligthart, Charlotte Elisabeth Teunissen, Eco J. C. de Geus · 2024 · Alzheimer s & Dementia
Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice
Diego Centonze, Alessia Di Sapio, Vincenzo Brescia Morra, Elena Colombo, Matilde Inglese, Damiano Paolicelli, Marco Salvetti, Roberto Furlan · 2025 · Frontiers in Neurology
Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarker
Juliana E Gentile, Christina N. Heiss, Taylor L Corridon, Meredith A Mortberg, Stefanie Fruhwürth, Kenia Guzman, Lana Grötschel, Laia Montoliu‐Gaya, Kwan Chan, Neil C Herring et al. · 2025 · Brain Communications
Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid
Lianne Maria Reus, Sven Stringer, Daniëlle Posthuma, Charlotte Elisabeth Teunissen, Philip Scheltens, Yolande A.L. Pijnenburg, Pieter Jelle Visser, Betty Marije Tijms · 2020 · Neurobiology of Aging
The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
Bernice Frempong, Robert B. Wilson, Kimberly A. Schadt, David R. Lynch · 2021 · Frontiers in Neuroscience
Biomarker clustering in autosomal dominant Alzheimer's disease
Patrick H. Luckett, Charlie Chen, Brian Andrew Gordon, Julie K. Wisch, Sarah B. Berman, Jasmeer P. Chhatwal, Carlos Cruchaga, Anne M. Fagan, Martin Rhys Farlow, Nick C. Fox et al. · 2022 · Alzheimer s & Dementia
Increased levels of neurofilament light chain in suicide attempters’ serum
Mahtab Ramezani, Leila Simani, Mahdiye Golestani Fard, Fatemeh Abbaszadeh, Shahin Shadnia · 2022 · Translational Neuroscience